Doximity Inc
For the period ended Mar 31, 2024. Filed May 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 23, 2024
DOCS$32.87+1.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands, except per share data)
| As of March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $96,785 | $158,027 |
| Marketable securities | 666,115 | 682,972 |
| Accounts receivable, net of allowance for doubtful accounts of $1,893 and $887 as of March 31, 2024 and 2023, respectively | 101,332 | 107,047 |
| Prepaid expenses and other current assets | 48,709 | 27,407 |
| Total current assets | 912,941 | 975,453 |
| Property and equipment, net | 12,318 | 11,279 |
| Deferred income tax assets | 45,068 | 34,907 |
| Operating lease right-of-use assets | 12,332 | 13,819 |
| Intangible assets, net | 27,317 | 31,836 |
| Goodwill | 67,940 | 67,940 |
| Other assets | 1,458 | 1,654 |
| Total assets | $1,079,374 | $1,136,888 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,253 | $1,272 |
| Accrued expenses and other current liabilities | 43,703 | 31,245 |
| Deferred revenue, current | 99,145 | 105,238 |
| Operating lease liabilities, current | 2,149 | 1,752 |
| Total current liabilities | 147,250 | 139,507 |
| Deferred revenue, non-current | 211 | 198 |
| Operating lease liabilities, non-current | 12,397 | 13,885 |
| Contingent earn-out consideration liability, non-current | 10,895 | 15,942 |
| Other liabilities, non-current | 7,224 | 1,240 |
| Total liabilities | 177,977 | 170,772 |
| Commitments and contingencies (Note 15) | ||
| Stockholders’ Equity | ||
| Preferred stock, $0.001 par value; 100,000 shares authorized as of March 31, 2024 and 2023, respectively; zero shares issued and outstanding as of March 31, 2024 and 2023, respectively | — | — |
| Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of March 31, 2024 and 2023, respectively; 186,562 and 193,941 shares issued and outstanding as of March 31, 2024 and 2023, respectively | 187 | 194 |
| Additional paid-in capital | 823,885 | 762,150 |
| Accumulated other comprehensive loss | (2,664) | (14,083) |
| Retained earnings | 79,989 | 217,855 |
| Total stockholders' equity | 901,397 | 966,116 |
| Total liabilities and stockholders’ equity | $1,079,374 | $1,136,888 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.